In this multicenter , randomized , double-masked , parallel controlled study , patients with open-angle glaucoma or ocular hypertension who were insufficiently responsive to monotherapy with either topical - blockers or prostaglandin analogues were randomized to one of two active treatment groups in a 1:1 ratio at 11 Chinese ophthalmic departments .